Brief: Robert Davidow Reports 14.5 % Passive Stake In Avenue Therapeutics
28/11/2023 22:44
Nov 28 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* ROBERT DAVIDOW REPORTS 14.5 % PASSIVE STAKE IN AVENUE
THERAPEUTICS, INC AS OF OCT 31, 2023 - SEC FILING
Source text for Eikon: ID:
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary